Stockscreener 앱 받기
9.10
0.22%
0.02
시간 외 거래:
3.43
-5.67
-62.31%
전일 마감가:
$9.08
열려 있는:
$8.94
하루 거래량:
1.54M
Relative Volume:
2.06
시가총액:
$1.34B
수익:
$340.46M
순이익/손실:
$98.11M
주가수익비율:
-52.12
EPS:
-0.1746
순현금흐름:
$43.17M
1주 성능:
-0.66%
1개월 성능:
+0.44%
6개월 성능:
+34.22%
1년 성능:
+1.68%
1일 변동 폭
$8.93
$9.22
1주일 범위
$8.93
$9.60
52주 변동 폭
$5.47
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
명칭
Mimedx Group Inc
전화
(770) 651-9100
주소
1775 W OAK COMMONS COURT, NE, MARIETTA
MDXG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.72 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1402 | 295.87M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.6475 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.32 | 142.97M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.01 | 52.16M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-03-07 | 개시 | Lake Street | Buy |
| 2023-10-27 | 개시 | Craig Hallum | Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-07-26 | 개시 | Northland Capital | Outperform |
| 2021-03-19 | 개시 | H.C. Wainwright | Buy |
모두보기
Mimedx Group Inc 주식(MDXG)의 최신 뉴스
MIMEDX Group's SWOT analysis: wound care firm's stock faces market headwinds - Investing.com
MIMEDX Files Patent Infringement Lawsuit Against Surgenex - GlobeNewswire
MiMedx Group (MDXG) Files Patent Infringement Lawsuit Against Surgenex - StreetInsider.com
MIMEDX Battles Patent Infringement: Files Major Lawsuit Over Placental Allograft Technology - StockTitan
MiMedx extends corporate HQ lease, ensures director indemnification - Investing.com
MiMedx extends corporate HQ lease, ensures director indemnification By Investing.com - Investing.com UK
(MDXG) On The My Stocks Page - Stock Traders Daily
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE P - The Eastern Progress Online
MIMEDX Group's SWOT analysis: wound care firm's stock faces growth hurdles - Investing.com Nigeria
MiMedx Group, Inc. (NASDAQ:MDXG) Stock Holdings Lifted by Charles Schwab Investment Management Inc. - MarketBeat
Amniotic Membrane Market Expected to Reach Huge Growth by 2031 | - openPR
MiMedx Group (NASDAQ:MDXG) shareholder returns have been decent, earning 39% in 3 years - Simply Wall St
Brokerages Set MiMedx Group, Inc. (NASDAQ:MDXG) PT at $12.00 - MarketBeat
MDXG stock soars to 52-week high, touches $9.66 By Investing.com - Investing.com South Africa
How the (MDXG) price action is used to our Advantage - Stock Traders Daily
MDXG stock soars to 52-week high, touches $9.66 - Investing.com India
MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire
MIMEDX to Present at Three Major Healthcare Investor Conferences in December - StockTitan
Institutional investors own a significant stake of 43% in MiMedx Group, Inc. (NASDAQ:MDXG) - Yahoo Finance
MiMedx Group Q3 2024 Earnings Preview - MSN
Isthmus Partners LLC Trims Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group Stock Soars to 52-Week High of $9.62 By Investing.com - Investing.com South Africa
MiMedx Group Stock Soars to 52-Week High of $9.62 - Investing.com India
MDXG (MiMedx Group) 3-Year Book Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
MDXG (MiMedx Group) Net Income From Continuing Operations : $85.8 Mil (TTM As of Sep. 2024) - GuruFocus.com
Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology - Benzinga
MDXG (MiMedx Group) 3-Year Revenue Growth Rate : -1.30% (As of Sep. 2024) - GuruFocus.com
(MDXG) Investment Report - Stock Traders Daily
MDXG (MiMedx Group) Total Liabilities : $62.9 Mil (As of Sep. 2024) - GuruFocus.com
How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12% - Yahoo Finance
MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year HighHere's Why - MarketBeat
Mizuho increases MiMedx stock target, rating held on Medicare decision - Investing.com
Mizuho increases MiMedx stock target, rating held on Medicare decision By Investing.com - Investing.com Canada
MiMedx stock soars to 52-week high, touches $9.28 - Investing.com India
MiMedx stock soars to 52-week high, touches $9.28 By Investing.com - Investing.com Canada
MiMedx Group (NASDAQ:MDXG) Shares Gap UpShould You Buy? - MarketBeat
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for - GlobeNewswire
MIMEDX Products Secure Medicare Coverage as 200+ Competitors Cut from 2025 LCD Update | MDXG Stock News - StockTitan
(MDXG) Trading Advice - Stock Traders Daily
Analysts Set MiMedx Group, Inc. (NASDAQ:MDXG) Price Target at $12.00 - MarketBeat
MiMedx Group (NASDAQ:MDXG) Downgraded to Buy Rating by StockNews.com - MarketBeat
Trigran Investments, Inc. Expands Stake in MiMedx Group Inc - GuruFocus.com
MiMedx Group's (NASDAQ:MDXG) Promising Earnings May Rest On Soft Foundations - Yahoo Finance
There's No Escaping MiMedx Group, Inc.'s (NASDAQ:MDXG) Muted Earnings Despite A 27% Share Price Rise - Simply Wall St
Mimedx Group Inc (MDXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mimedx Group Inc 주식 (MDXG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hulse William Frank IV | General Counsel and CAO |
Mar 13 '24 |
Sale |
7.95 |
20,381 |
162,029 |
479,959 |
| Whitlow Ricci S | Chief Operating Officer |
Feb 16 '24 |
Sale |
8.07 |
15,493 |
125,075 |
416,321 |
| Whitlow Ricci S | Chief Operating Officer |
Feb 20 '24 |
Sale |
8.01 |
15,271 |
122,351 |
401,050 |
| Whitlow Ricci S | Chief Operating Officer |
Feb 14 '24 |
Sale |
8.03 |
15,845 |
127,267 |
447,012 |
| Whitlow Ricci S | Chief Operating Officer |
Feb 15 '24 |
Sale |
8.06 |
15,198 |
122,496 |
431,814 |
2.88%
2.65%
자본화:
|
볼륨(24시간):